Piperacillin and tazobactam and Left ventricular dysfunction - a phase IV clinical study of FDA data
Summary:
Left ventricular dysfunction is reported as a side effect among people who take Piperacillin and tazobactam (piperacillin sodium; tazobactam sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Potassium, and have Immunodeficiency.
The phase IV clinical study analyzes which people have Left ventricular dysfunction when taking Piperacillin and tazobactam. It is created by eHealthMe based on reports of 12,649 people who have side effects when taking Piperacillin and tazobactam from the FDA, and is updated regularly.
What is Piperacillin and tazobactam?
Piperacillin and tazobactam has active ingredients of piperacillin sodium; tazobactam sodium. eHealthMe is studying from 12,660 Piperacillin and tazobactam users. Check the latest studies of Piperacillin and tazobactam.
What is Left ventricular dysfunction?
Left ventricular dysfunction is found to be associated with 888 drugs and 793 conditions by eHealthMe. Check the latest studies of Left ventricular dysfunction.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12,649 people reported to have side effects when taking Piperacillin and tazobactam.
Among them, 11 people (0.09%) have Left ventricular dysfunction.

Among these 11 people:
How long have people been on Piperacillin and tazobactam when they have Left ventricular dysfunction? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Left ventricular dysfunction when taking Piperacillin and tazobactam? *
- female: 30 %
- male: 70 %
What is the age of people who have Left ventricular dysfunction when taking Piperacillin and tazobactam? *
- 0-1: 0.0 %
- 2-9: 11.11 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 11.11 %
- 50-59: 22.22 %
- 60+: 55.56 %
What are other drugs people take besides Piperacillin and tazobactam? *
- Ibrutinib: 2 people, 18.18%
- Nitroglycerin: 2 people, 18.18%
- Aspirin: 2 people, 18.18%
- Augmentin: 2 people, 18.18%
- Bisoprolol Fumarate: 2 people, 18.18%
- Clopidogrel: 2 people, 18.18%
- Eliquis: 2 people, 18.18%
- Skyrizi: 2 people, 18.18%
- Allopurinol: 2 people, 18.18%
- Potassium: 2 people, 18.18%
What are other side effects people have besides Left ventricular dysfunction? *
- Dyspnea (difficult or laboured breathing): 7 people, 63.64%
- Pulmonary Oedema (fluid accumulation in the lungs): 6 people, 54.55%
- Fever: 5 people, 45.45%
- Pleural Effusion (water on the lungs): 5 people, 45.45%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 36.36%
- Hypotension (abnormally low blood pressure): 4 people, 36.36%
- C-Reactive Protein Increased: 4 people, 36.36%
- Pneumonia: 4 people, 36.36%
- Drug Hypersensitivity: 3 people, 27.27%
- Haemoglobin Decreased: 3 people, 27.27%
What are the existing conditions these people have? *
- Secondary Immunodeficiency (lack of immunity due to some disease): 2 people, 18.18%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 18.18%
- Pain In Extremity: 2 people, 18.18%
- Lower Respiratory Tract Infection Bacterial: 2 people, 18.18%
- Immunodeficiency: 2 people, 18.18%
- Transitional Cell Carcinoma Metastatic (cancer of urinary inner most layer spreads to other part of body): 1 person, 9.09%
- Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 9.09%
- Septic Shock (shock due to blood infection): 1 person, 9.09%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
- Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Piperacillin and tazobactam and have Left ventricular dysfunction?
- Check whether Left ventricular dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Piperacillin and tazobactam:
- Piperacillin and tazobactam (12,660 reports)
Left ventricular dysfunction treatments and more:
- Left ventricular dysfunction (8,945 reports)
How severe was Left ventricular dysfunction and when was it recovered:
Expand to all the drugs that have ingredients of piperacillin sodium; tazobactam sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Piperacillin and tazobactam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Left ventricular dysfunction:
- Left ventricular dysfunction (888 drugs)
Browse all the conditions that are associated with Left ventricular dysfunction:
- Left ventricular dysfunction (793 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on piperacillin sodium; tazobactam sodium (the active ingredients of Piperacillin and tazobactam) and Piperacillin and tazobactam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ramipril and Genvoya - 10 seconds ago
- Could Ursodiol cause Gastroenteritis Norovirus? - 10 seconds ago
- Could Methotrexate cause Colitis Microscopic? - 21 seconds ago
- Idiopathic Pulmonary Fibrosis and Renal Cell Carcinoma - 24 seconds ago
- Drug interactions of Nivestym and Revlimid - 35 seconds ago
- Drug interactions of Ludiomil and Levothyroxine Sodium - 36 seconds ago
- Could Ceftriaxone cause Death? - 37 seconds ago
- Could Cobamamide cause Joint Pain? - 41 seconds ago
- Drug interactions of Cevimeline and Fish Oil - 41 seconds ago
- Desogestrel; Ethinyl vs. Slynd, side effect and effectiveness comparison - 49 seconds ago